VIVEbiotech is participating at the American Society of Gene & Cell Therapy´s Annual Meeting in Baltimore
VIVEbiotech is participating at the American Society of Gene & Cell Therapy´s (ASGCT) Annual Meeting at the Baltimore Convention Center.
Natalia Elizalde, Chief Business Development Officer, gave a company presentation yesterday about VIVEbiotech´s virology and bioprocess expertise, and their direct, positive impact on the good results obtained on our plug-and-play manufacturing platform. Aroused a lot of interest!
In addition to Natalia, Jon Alberdi, Managing Director, and Giovanna Zanella, Head of Technical Proposals and Project Manager, will be happy to chat with you about your specific lentiviral vector needs at booth nr. 1232.
They are eager to see old friends and meet new ones, and to search, together, for solutions that can save lives.
